| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.42 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |